NEUROPACE, INC. Interest Expense Nonoperating
NEUROPACE, INC. (NPCE) reported Interest Expense Nonoperating of $1.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-11
- NEUROPACE, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $1.54M, a 25.25% decline year-over-year.
- NEUROPACE, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $1.52M, a 29.35% decline year-over-year.
- NEUROPACE, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $1.60M, a 27.01% decline year-over-year.
- NEUROPACE, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $1.65M, a 24.61% decline year-over-year.
- NEUROPACE, INC. interest expense nonoperating for fiscal 2025 was $7.46M, a 15.24% decline from fiscal 2024.
- NEUROPACE, INC. interest expense nonoperating for fiscal 2024 was $8.80M, a 3.30% increase from fiscal 2023.
- NEUROPACE, INC. interest expense nonoperating for fiscal 2023 was $8.52M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.54M 10-Q · filed 2026-08-11 | $3.06M 10-Q · filed 2026-08-11 | $4.66M derived: sum of 3 quarters · filed 2026-08-11 | $6.30M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.52M 10-Q · filed 2026-05-12 | $3.12M derived: sum of 2 quarters · filed 2026-05-12 | $4.77M derived: sum of 3 quarters · filed 2026-05-12 | $6.83M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.25M derived: sum of 2 quarters · filed 2026-03-03 | $5.30M derived: sum of 3 quarters · filed 2026-08-11 | $7.46M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.65M 10-Q · filed 2025-11-04 | $3.70M derived: sum of 2 quarters · filed 2026-08-11 | $5.86M 10-Q · filed 2025-11-04 | $8.05M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.06M 10-Q · filed 2026-08-11 | $4.21M 10-Q · filed 2026-08-11 | $6.40M derived: sum of 3 quarters · filed 2026-08-11 | $8.59M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $2.15M 10-Q · filed 2026-05-12 | $4.34M derived: sum of 2 quarters · filed 2026-05-12 | $6.53M derived: sum of 3 quarters · filed 2026-05-12 | $8.69M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $4.37M derived: sum of 2 quarters · filed 2026-03-03 | $6.54M derived: sum of 3 quarters · filed 2026-03-03 | $8.80M 10-K · filed 2026-03-03 |
| 2024-09-30 | $2.18M 10-Q · filed 2025-11-04 | $4.35M derived: sum of 2 quarters · filed 2025-11-04 | $6.61M 10-Q · filed 2025-11-04 | $8.84M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.17M 10-Q · filed 2025-08-12 | $4.42M 10-Q · filed 2025-08-12 | $6.66M derived: sum of 3 quarters · filed 2025-08-12 | $8.85M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.26M 10-Q · filed 2025-05-13 | $4.49M derived: sum of 2 quarters · filed 2025-05-13 | $6.68M derived: sum of 3 quarters · filed 2025-05-13 | $8.81M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $4.43M derived: sum of 2 quarters · filed 2025-03-04 | $6.55M derived: sum of 3 quarters · filed 2025-03-04 | $8.52M 10-K · filed 2025-03-04 |
| 2023-09-30 | $2.19M 10-Q · filed 2024-11-12 | $4.32M derived: sum of 2 quarters · filed 2024-11-12 | $6.28M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $2.13M 10-Q · filed 2024-08-13 | $4.09M 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |